Examination of multiple medication use among TRICARE beneficiaries aged 65 years and older

Journal of Managed Care Pharmacy

Volumn 13, Issue 2, 2007, Pages 155-162

  Linton, Andrea ^a,c   Garber, Mathew ^b   Fagan, Nancy K ^a   Peterson, Michael R ^a  

^a OASD(HA)/TMA/HPA and E   (United States)

^b Pharmacy Programs   (United States)

^c HPA and E   (United States)

Author keywords

Department of Defense; Senior drug utilization; TRICARE

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALENDRONIC ACID; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTITHYROID AGENT; ANTITUSSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE ANTAGONIST; PROTON PUMP INHIBITOR; RENIN INHIBITOR; TAMSULOSIN; VITAMIN B COMPLEX; XANTHINE OXIDASE INHIBITOR;

AGED; ARTICLE; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE ORGANIZATION; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACEUTICAL CARE; PRESCRIPTION; STATISTICAL SIGNIFICANCE; STUDENT T TEST;

EID: 33947703589     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2007.13.2.155     Document Type: Article

References (31)

1. Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs. 2005;31(9):4-11.
2. Prybys K, Melville K, Hanna J, Gee A, Chyka P. Polypharmacy in the elderly; clinical challenges in emergency practice: part 1: overview, etiology, and drug interactions. Emerg Med Rep. 2002;23(11):145-53.
3. Bretherton A, Day L, Lewis G. Polypharmacy and older people. Nurs Times. 2003;99(17):54-55.
4. Beers M. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med. 1997;157(14):1531-36.
5. Zhan C, Sangl J, Beirman AS, et al. Potentially inappropriate medication use in the community-dwelling elderly JAMA. 2001;286:2823-29.
6. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med. 2003;163:2716-24.
7. Kaufman MB, Brodin KA, Sarafian A. Effect of prescriber education on the use of medications contraindicated in older adults in a managed care population. J Manag Care Pharm. 2005;11(3):211-19. Available at: http://www.amcp.org/data/jmcp/Research_211-219.pdf. Accessed September 12, 2005.
8. Hohl CM, Dankoff J, Colacone A, Afilalo M. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med. 2001;38(6):666-71.
9. Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract. 2005;17(4):123-32.
10. Rusk KJ, Wells KJ, Teitel GS, Hawley JN, Richards C, Gazmararian JA. Can an algorithm for appropriate prescribing predict adverse drug events? Am J Manag Care. 2005;11(3):145-51.
11. Veehof LJ, Stewart RE, Meyboom-de Jong B, Haaijer-Ruskamp FM Adverse drug reactions and polypharmacy in the elderly in general practice. Eur J Clin Pharmacol. 1999;55(7):553-56.
12. Kurfees JF, Dotson RL. Drug interactions in the elderly. J Fam Pract. 1987;25(5):477-88.
13. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348(16):1556-64.
14. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289:1107-16.
15. Rector TS, Venus PJ. Do drug benefits help Medicare beneficiaries afford prescribed drugs? Health Aff. 2004;23(4):213-22.
16. Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: findings from a 2003 national survey. Health Aff. April 19, 2005. Available at: http://content.healthaffairs.org/cgi/content/ citation/hlthaff.w5.152/DC1. Accessed December 27, 2005.
17. Office of the Assistant Secretary of Defense (Health Affairs) and the TRICARE Management Activity TRICARE pharmacy homepage. Available at: http://www.tricare.mil/pharmacy/default.cfm. Accessed April 27, 2005.
18. Glazer G, Turkoski B, Kalinyak C, Bro A. Medication use by health midlife women. A revealing study in polypharmacy. Adv Nurse Pract. 2002;19(3):59-64, 122.
19. Perry BA, Turner LW. A prediction model for polypharmacy: are older, educated women more susceptible to an adverse drug event? J Women Aging. 2001;13(4):39-51.
20. Fillit HM, Futterman R, Orland BI, et al. Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviews. Am J Manag Care. 1999;5(5):587-94.
21. Fincke BG, Knyder D, Cantillon C, et al. Three complementary definitions of polypharmacy: methods, application, and comparison of findings in a large prescription database. Pharmacoepidemiol Drug Safety. 2005;14(2):121-28.
22. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287(3):337-44.
23. Veehof L, Stewart R, Haaijer-Rusdamp F, Jong BM. The development of polypharmacy. A longitudinal study. Fam Pract. 2000;17(3):261-67.
24. Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivela SL, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol. 2002;55(8):809-17.
25. Bjerrum L, Sogaard J, Hallas J, Kragstrup J. Polypharmacy: correlations with sex, age, and drug regimen. A prescription database study. Eur J Clin Pharmacol. 1998;54(3):197-202.
26. Tepper DC, Lied TR. Trends in Medicaid prescribed drug expenditures and utilization. Health Care Financ Rev. 2004;25(3):69-78.
27. Masoudi FA, Baillie CA, Wang Y, et al. The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001. Arch Intern Med. 2005;165(18):2069-76.
28. Cleland JGF, Baksh A, Louis A. Polypharmacy (or polytherapy) in the treatment of heart failure. Heart Fail Monit. 2000;1(1):8-13.
29. Trygstad TK, Christensen D, Garmise J, Sullivan R, Wegner S. Pharmacist response to alerts generated from Medicaid pharmacy claims in a long-term care setting: results from the North Carolina Polypharmacy Initianve. J Manag Care Pharm. 2005;11(7):575-83. Available at: http://www.amcp.org/data/jmcp/Contemporary%20Subjects_575_583.pdf. Accessed September 12, 2005.
30. Zarowitz BJ, Stebelsky LA, Muma BK, Romain TM, Peterson EL. Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting. Pharmacotherapy. 2005;25(11):1636-45.
31. Bushardt RL, Jones KW. Nine key questions to address polypharmacy in the elderly. JAAPA. 2005;18(5):32-37.